Met-Enkephalin CAS NO.58569-55-4

Met-Enkephalin CAS NO.58569-55-4

Met-Enkephalin CAS NO.58569-55-4

Met-Enkephalin CAS NO.58569-55-4

Met-Enkephalin CAS NO.58569-55-4

Met-Enkephalin (Tyr-Gly-Gly-Phe-Met) is a naturally occurring pentapeptide and an endogenous opioid peptide. It is one of the two primary enkephalins, derived from the precursor protein proenkephalin, and acts as a neurotransmitter and neuromodulator in the central and peripheral nervous systems. It plays a key role in pain modulation, reward, mood, and stress responses. This high-purity synthetic peptide is an essential tool for neuroscience, pharmacology, and pain research.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Met-Enkephalin
CAS NO.
58569-55-4
Appearance
White to off-white lyophilized powder
Molecular Formula
C27H35N5O7S
Molecular Weight
573.67g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥1–5 mg/mL), DMSO (≥23–40 mg/mL); also soluble in aqueous buffers and dilute acetic acid.

Endotoxin< 1.0 EU/mg (Typical for research-grade peptides)
Biological Activity
Endogenous opioid peptide; potent agonist at mu (MOR), delta (DOR), and zeta-opioid receptors; exhibits analgesic, immunomodulatory, anti-inflammatory, and antinociceptive properties; regulates immune function and inhibits tumor growth via opioid receptor binding.
Storage Conditions
-20°C (1 year stability) or -80°C (2 years stability); desiccated, sealed, and protected from moisture/light; avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Met-Enkephalin primarily exerts its effects by binding to and activating δ-opioid (DOP) and μ-opioid (MOP) receptors as an agonist. Its mechanism involves:

  1. Receptor Activation: It binds with higher affinity to δ-opioid receptors, but also activates μ-opioid receptors.
  2. G-protein Coupling: Receptor activation inhibits adenylate cyclase, reducing intracellular cAMP levels.
  3. Ion Channel Modulation: It opens G-protein-coupled inwardly rectifying potassium (GIRK) channels, causing neuronal hyperpolarization, and inhibits voltage-gated calcium channels, reducing neurotransmitter release (e.g., glutamate, substance P).
  4. Pain Signal Inhibition: This combined action suppresses the transmission of pain signals at spinal and supraspinal levels, producing analgesia.


2.PRODUCT INDICATIONS

This product is indicated for a wide range of in vitro and in vivo research applications, including:

  • Neuroscience & Pain Research: Investigating endogenous pain control systems, analgesia, and the pathophysiology of chronic pain.
  • Neuropharmacology: Studying opioid receptor function, signaling, and the effects of receptor agonists/antagonists.
  • Psychiatry & Addiction Research: Exploring its role in reward pathways, mood regulation, stress responses, and substance use disorders.
  • Immunology: Researching the interaction between the opioid and immune systems (e.g., on immune cell function).
  • Cell Signaling & Biochemistry: Used as a ligand in receptor binding assays and to study G-protein mediated signaling pathways.


3.CLINICAL EFFICACY OF PRODUCT

As an endogenous neuropeptide, Met-Enkephalin itself is not used as a direct therapeutic due to its rapid enzymatic degradation (by peptidases like NEP and ACE). However, its physiological role is fundamental, and strategies to enhance its activity are clinically relevant.

  • Validated Therapeutic Target: The enkephalinergic system is a major target for pain management. The clinical efficacy of targeting this pathway is demonstrated by opioid analgesics that act on the same receptors (MOP/DOP).
  • Enkephalinase Inhibitors: Drugs that inhibit the enzymes that degrade enkephalins (e.g., racecadotril) are used clinically for conditions like diarrhea, based on enhancing endogenous enkephalin activity in the gut.
  • Prototype for Drug Development: Met-Enkephalin serves as the lead structure for developing more stable, potent, and receptor-selective analgesic peptides, aiming for pain relief with fewer side effects than traditional opioids.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.